OXICODONA HEXAL 80 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG Испания - испански - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

oxicodona hexal 80 mg comprimidos de liberacion prolongada efg

hexal ag - oxicodona hidrocloruro - excipientes: etanol anhidro,azucar , esferas de,propilenglicol - opioides - alcaloides naturales del opio - oxicodona

Clopidogrel Acino Европейски съюз - испански - EMA (European Medicines Agency)

clopidogrel acino

acino ag - clopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - agentes antitrombóticos - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.

Iblias Европейски съюз - испански - EMA (European Medicines Agency)

iblias

bayer ag - octocog alfa - hemofilia a - antihemorrágicos - tratamiento y profilaxis de hemorragias en pacientes con hemofilia a (deficiencia congénita de factor viii). iblias puede ser utilizado para todos los grupos de edad.

Kovaltry Европейски съюз - испански - EMA (European Medicines Agency)

kovaltry

bayer ag - octocog alfa - hemofilia a - antihemorrágicos - tratamiento y profilaxis de hemorragias en pacientes con hemofilia a (deficiencia congénita de factor viii). kovaltry se puede utilizar para todos los grupos de edad.

Xarelto Европейски съюз - испански - EMA (European Medicines Agency)

xarelto

bayer ag - rivaroxaban - arthroplasty, replacement; venous thromboembolism - agentes antitrombóticos - xarelto, co-administrado con ácido acetilsalicílico (aas), solos o con aas más clopidogrel o ticlopidina, está indicado para la prevención de eventos aterotrombóticos en pacientes adultos después de un síndrome coronario agudo (sca) con elevación de biomarcadores cardiacos. xarelto, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. prevención del tromboembolismo venoso (tev) en pacientes adultos sometidos a cirugía electiva de reemplazo de cadera o rodilla. tratamiento de la trombosis venosa profunda (tvp) y embolia pulmonar (pe), y la prevención de la recurrencia de la tvp y de la ep en los adultos. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.